Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long‐term use of low‐dose aspirin: A retrospective study of 612 509 patients

Kelvin Tsoi, Felix C.h. Chan, Hoyee W. Hirai, Joseph J.�y. SungJournal of Gastroenterology and Hepatology 2018 · DOI

Abstract

The long-term use of aspirin reduces both incidence and mortality of CRC and at the same time increases incidence and mortality risk of GIB. With combination use of acid-secreting agents, the bleeding risk can be reduced.
BibTeX
@article{tsoi2018risk,
  author = {Kelvin Tsoi and Felix C.H. Chan and Hoyee W. Hirai and Joseph J.�Y. Sung},
  title = {{Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long‐term use of low‐dose aspirin: A retrospective study of 612 509 patients}},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2018},
  doi = {10.1111/jgh.14261},
}

Loading related content...

Figure